Hereditary cataracts are the most common inherited eye disease in the Australian Shepherd, and the breed carries a known risk mutation in a gene called HSF4 at a strikingly high frequency — roughly one in four Aussies. But this is one of those conditions where a DNA test alone gives a dangerously incomplete picture. A dog can test “clear” of the mutation and still go blind from cataracts; another can carry the mutation and never develop a problem. Understanding why means understanding the difference between a risk gene and a diagnosis — and why responsible Aussie breeders run both a DNA test and an ophthalmologist’s exam, every year.
What HSF4 does and how it’s inherited
HSF4 stands for heat shock transcription factor 4. It is a gene active in the lens of the eye, where it helps regulate the orderly development and maintenance of the transparent lens fibres. When the lens proteins lose their precise arrangement, they clump and cloud — and that cloudiness is a cataract. The Australian Shepherd carries a specific HSF4 variant associated with cataracts that are typically bilateral (both eyes) and often start at the back of the lens.
The inheritance pattern is what makes HSF4 tricky. It behaves as autosomal dominant with incomplete penetrance. Three phrases worth unpacking:
- Dominant: a single copy of the mutation can predispose a dog to cataracts. Unlike recessive diseases, you do not need two copies to be at risk.
- Incomplete penetrance: carrying the mutation raises the odds of cataracts but does not guarantee them. Many dogs with one copy never develop a clinical cataract in their lifetime.
- Dose effect: dogs with two copies (homozygous) tend to develop cataracts earlier and more severely than dogs with one copy.
So the HSF4 test does not tell you whether a dog has cataracts. It tells you the dog’s genetic risk of developing them. That distinction is the whole point.
“At-risk” is not the same as “affected”
This is where many owners get tripped up, so it is worth stating plainly:
- At-risk describes a genotype — the dog carries one or two copies of the HSF4 mutation, as revealed by a DNA test. It is a probability, present from birth and unchanging.
- Affected describes a phenotype — the dog actually has cataracts, as seen by an ophthalmologist looking into the eye. It is an observed fact that can appear, or change, over the dog’s life.
The two do not map neatly onto each other. An at-risk dog may live a long life with clear eyes. And — crucially — a genetically clear dog can still develop cataracts, because HSF4 is only one cause among many. Cataracts also arise from other genes not yet identified, from diabetes, from trauma, from inflammation inside the eye, from progressive retinal atrophy, and simply from old age. A “clear” HSF4 result rules out that one mutation; it does not certify a lifetime of perfect eyes.
This is exactly why testing for a single gene, while valuable, can never substitute for actually examining the organ — a theme that runs through inherited eye disease generally, including the structural defect described in our article on Collie Eye Anomaly genetics.
Why the DNA test and the CAER exam are partners, not substitutes
Responsible Australian Shepherd breeders treat genetic testing and clinical screening as two halves of one assessment. Each catches what the other misses.
The HSF4 DNA test is done once, from a cheek swab or blood sample, and never changes. Its strength is foresight: it tells you a puppy’s risk before any cataract could possibly appear, which helps plan a mating years in advance. Its weakness is that it sees only the HSF4 gene and only predicts probability, not outcome.
The eye examination — in North America performed by a board-certified veterinary ophthalmologist and recorded through the CAER scheme (Companion Animal Eye Registry, run by the OFA), and through equivalent ECVO panels elsewhere — looks directly into the eye and reports what is actually there. Its strength is that it detects real cataracts from any cause, plus other eye diseases entirely. Its weakness is that it is a snapshot in time: a dog with clear eyes today can develop a cataract next year, which is why these exams are repeated annually for breeding dogs rather than done once.
Put together, the logic for a breeding programme is:
- Run the HSF4 DNA test to know each dog’s genetic risk and avoid stacking risk in a mating.
- Run annual CAER/ophthalmologist exams to catch cataracts (and other conditions) that the gene test cannot predict.
- Treat a dog with developing inherited cataracts cautiously in breeding decisions regardless of its DNA result, because the eye exam reflects reality.
Practical breeding decisions
Because HSF4 is dominant with incomplete penetrance, breeders generally aim to avoid producing homozygous (two-copy) puppies, since those carry the highest and earliest risk. In practice that means not mating two at-risk dogs together; pairing an at-risk dog with a clear partner keeps any single copy from doubling up. Over generations this lowers the frequency of the mutation without forcing breeders to discard otherwise excellent dogs that happen to carry one copy — an approach consistent with sound breeding practice for any predisposing variant.
For pet owners, the message is simpler but still useful. If your Aussie carries the HSF4 mutation, it does not mean blindness is coming — but it is a reason to keep up with veterinary eye checks, especially in middle age, so that if a cataract does form it is caught early. Cataract surgery is highly successful in dogs when done before complications set in.
The broader lesson HSF4 teaches is one that applies across canine genetics: a DNA test is a powerful tool, but it answers a narrow question. For a disease with many causes and incomplete penetrance, the genotype and the clinical exam each tell half the story — and only together do they let a breeder make a genuinely informed decision.